We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Third Generation Assay Determines Parathyroid Hormone Levels

By LabMedica International staff writers
Posted on 13 Jul 2011
A chemiluminescent immunoassay was released for the quantitative determination of parathyroid hormone (PTH) levels.

The new assay, dubbed Liaison1-84 PTH, determines PTH in serum and ethylenediaminetetraacetic acid (EDTA)-plasma, without cross-reactivity with the 7-84 PTH fragment.

An antibody, which is highly specific for the N-terminus of the peptide ensures 100% specificity for the whole PTH molecule and eliminates the problem of interference due to N-terminal fragments. The Liaison1-84 PTH assay is therefore able to provide uniformity of results even in patients with kidney disease, who tend to accumulate these fragments in high concentrations.

DiaSorin (Turin, Italy) added the fully automated Liaison1-84 PTH assay to its bone and mineral panel, which includes Liaison 25-OH Vitamin D Total, Liaison N-TACT PTH, Liaison BAP Ostase, and Liaison Osteocalcin. The completed panel assesses and monitors bone metabolism diseases.

Related Links:

DiaSorin



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Sample Transportation System
Tempus1800 Necto

Latest Clinical Chem. News

Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
13 Jul 2011  |   Clinical Chem.

Compact Raman Imaging System Detects Subtle Tumor Signals
13 Jul 2011  |   Clinical Chem.

Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
13 Jul 2011  |   Clinical Chem.